United Therapeutics (UTHR) Tops Q2 EPS by 82c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $237.00 +1.08%
Revenue Growth %: +22.3%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: +22.3%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.98, $0.82 better than the analyst estimate of $3.16. Revenue for the quarter came in at $444.5 million versus the consensus estimate of $368.58 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
- Alamos Gold (AGI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
